Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Biomolecules|November 24, 2022
Biodefensive Based on Piper nigrum Essential Oil for Controlling of Anopheles aquasalis Larvae: Influence of Temperature (35 °C) and PreservativesAyná Caroline Marcião Vieira, Sidney Gomes Azevedo, Ramon Andrade Linhares, et al.Expert Review of Neurotherapeutics|January 15, 2014
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?Yara D Fragoso, Niedja M Arruda, Walter O Arruda, et al.Journal of Child Neurology|April 24, 2019
Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early OnsetYara Dadalti Fragoso, Nise Alessandra C Sousa, Tania Saad, et al.Pediatric Neurology|October 18, 2013
Neuromyelitis optica with onset in childhood and adolescenceYara Dadalti Fragoso, Maria L B Ferreira, Enedina M L Oliveira, et al.Arquivos De Neuro-Psiquiatria|September 25, 2014
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosisYara Dadalti Fragoso, Christian Cardoso Arruda, Walter Oleschko Arruda, et al.Arquivos De Neuro-Psiquiatria|October 8, 2015
Cerebrum-cervical arterial dissection in adults during sports and recreationYara Dadalti Fragoso, Tarso Adoni, Lazaro Luiz Faria do Amaral, et al.Multiple Sclerosis and Related Disorders|December 4, 2018
Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)Yara Dadalti Fragoso, Nise Alessandra C Sousa, Soniza Vieira Alves-Leon, et al.Arquivos De Neuro-Psiquiatria|April 9, 2013
Natalizumab adverse events are rare in patients with multiple sclerosisYára Dadalti Fragoso, Soniza Vieira Alves-Leon, Walter Oleschko Arruda, et al.Arquivos De Neuro-Psiquiatria|October 27, 2018
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosisLuciana Prats Branco, Tarso Adoni, Samira Luisa Apostolos-Pereira, et al.Arquivos De Neuro-Psiquiatria|November 12, 2013
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positiveYara Dadalti Fragoso, Maria Fernanda Mendes, Walter Oleschko Arruda, et al.Pageof 4